Evidence map›Paper›PMID 17048048›Full record

ArticleJournal of gastroenterology2006

Leukocyte removal therapy for ulcerative colitis does not affect postoperative complications.

Hiroki Ikeuchi, Takehira Yamamura, Masato Kusunoki, Hiroki Nakano, Motoi Uchino, Mitsuhiro Nakamura, Masafumi Noda, Hidenori Yanagi, Takayuki Matsumoto

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hiroki IkeuchiSecond Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
Takehira Yamamura
Masato Kusunoki
Hiroki Nakano
Motoi Uchino
Mitsuhiro Nakamura
Masafumi Noda
Hidenori Yanagi
Takayuki Matsumoto
Hyogo Medical University · JPMie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe investigated the incidence of postoperative complications in patients treated with or without preoperative leukocyte removal therapy (LRT).

methodsThe case notes of 387 patients with ulcerative colitis (UC) who underwent surgical intervention were retrospectively reviewed. One hundred nine patients were treated with LRT within 8 weeks before surgery (LRT group), and 278 had not received LRT since at least 8 weeks before surgery (without LRT group). We reviewed the postoperative complications according to type of initial operation.

resultsOf the patients who underwent an ileal J-pouch anal anastomosis (IPAA) without an ileostomy, 3 (6.5%) in the LRT group developed pouch-related complications (PRC), while 11 (7.5%) in the without LRT group developed PRC. The overall postoperative complication rates were 28.3% in the LRT group and 21.8% in the without LRT group. For patients who underwent an IPAA with an ileostomy, the overall rates of postoperative complications were 39.1% in the LRT group and 31.8% in the without LRT group. Among those undergoing a total colectomy, 33.3% in the LRT group and 18.2% in the without LRT group had postoperative complications. No statistically significant differences were demonstrated between the two groups with respect to postoperative complications.

conclusionsOur results suggest that preoperative LRT does not influence the rate of postoperative complications in UC patients.

Indexed as

AdolescentAdultAgedColitis, UlcerativeColonic PouchesFemaleFollow-Up StudiesHumansIncidenceLeukocyte Reduction ProceduresMaleMiddle AgedPostoperative ComplicationsProctocolectomy, RestorativeRetrospective StudiesTreatment Outcome

Identifiers

PMID17048048
OpenAlexW2030997371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.